Azelis Extends Agreement with Tagra Biotechnologies

Azelis has been appointed as exclusive distributor of Tagra Biotechnologies' Release On Demand™ (RND™) microcapsules for all personal care applications in France and Benelux. This new partnership expands the existing collaboration between the two companies in Canada, China, India, Australia, New Zealand and a large part of Europe."Azelis is well positioned in France and Benelux to increase market penetration, and Tagra's patented technology for encapsulation of actives, UV filters and pigments is a welcome addition to our portfolio for these markets," says Tony Craske, Market Segment Director for Azelis EMEA. "Both companies are highly focused on innovation and Tagra's market-leading ingredients will help our customers improve overall product performance."